Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
Labcorp (NYSE: LH) has launched Test Finder, a pioneering generative AI tool developed in collaboration with Amazon Web Services (AWS). The tool aims to streamline laboratory test selection for healthcare providers by allowing them to input queries in plain language and receive curated test recommendations.
Test Finder, built using Amazon Bedrock and large language model technology, provides access to thousands of lab tests across multiple therapeutic areas. The tool addresses a significant healthcare challenge, as laboratory testing influences nearly 70% of clinical decisions, while physicians spend over three hours daily on documentation and test ordering. According to an AMA survey, 57% of physicians view administrative automation through AI as healthcare's greatest AI opportunity.
Labcorp (NYSE: LH) ha lanciato Test Finder, uno strumento innovativo basato sull'intelligenza artificiale generativa, sviluppato in collaborazione con Amazon Web Services (AWS). Questo strumento mira a semplificare la selezione dei test di laboratorio per i professionisti sanitari, permettendo loro di inserire richieste in linguaggio naturale e ricevere raccomandazioni personalizzate sui test.
Test Finder, realizzato utilizzando Amazon Bedrock e la tecnologia dei grandi modelli linguistici, offre accesso a migliaia di test di laboratorio in diverse aree terapeutiche. Lo strumento risponde a una sfida importante nel settore sanitario, dato che i test di laboratorio influenzano quasi il 70% delle decisioni cliniche, mentre i medici dedicano oltre tre ore al giorno alla documentazione e all'ordinazione dei test. Secondo un sondaggio dell'AMA, il 57% dei medici considera l'automazione amministrativa tramite l'IA la più grande opportunità offerta dall'intelligenza artificiale in ambito sanitario.
Labcorp (NYSE: LH) ha lanzado Test Finder, una innovadora herramienta de inteligencia artificial generativa desarrollada en colaboración con Amazon Web Services (AWS). Esta herramienta busca facilitar la selección de pruebas de laboratorio para los profesionales de la salud, permitiéndoles ingresar consultas en lenguaje natural y recibir recomendaciones personalizadas de pruebas.
Test Finder, construido con Amazon Bedrock y tecnología de grandes modelos de lenguaje, ofrece acceso a miles de pruebas de laboratorio en diversas áreas terapéuticas. La herramienta aborda un desafío importante en la atención médica, ya que las pruebas de laboratorio influyen en casi el 70% de las decisiones clínicas, mientras que los médicos dedican más de tres horas diarias a la documentación y solicitud de pruebas. Según una encuesta de la AMA, el 57% de los médicos considera que la automatización administrativa mediante IA es la mayor oportunidad que ofrece la inteligencia artificial en la salud.
Labcorp (NYSE: LH)는 Amazon Web Services(AWS)와 협력하여 개발한 혁신적인 생성형 AI 도구인 Test Finder를 출시했습니다. 이 도구는 의료 제공자가 자연어로 질의를 입력하면 맞춤형 검사 추천을 받을 수 있어 실험실 검사 선택 과정을 간소화하는 것을 목표로 합니다.
Amazon Bedrock과 대형 언어 모델 기술을 활용해 구축된 Test Finder는 여러 치료 분야에 걸쳐 수천 개의 실험실 검사를 제공합니다. 이 도구는 의료 분야의 중요한 문제를 해결하는데, 실험실 검사는 임상 결정의 거의 70%에 영향을 미치며, 의사들은 문서 작성과 검사 주문에 하루 평균 3시간 이상을 소비합니다. AMA 설문조사에 따르면, 의사의 57%가 AI를 통한 행정 자동화를 의료 분야에서 가장 큰 AI 기회로 보고 있습니다.
Labcorp (NYSE : LH) a lancé Test Finder, un outil innovant d'IA générative développé en collaboration avec Amazon Web Services (AWS). Cet outil vise à simplifier la sélection des tests de laboratoire pour les professionnels de santé en leur permettant de saisir des requêtes en langage naturel et de recevoir des recommandations de tests personnalisées.
Test Finder, conçu avec Amazon Bedrock et la technologie des grands modèles de langage, donne accès à des milliers de tests de laboratoire dans plusieurs domaines thérapeutiques. Cet outil répond à un défi majeur en santé, car les tests de laboratoire influencent près de 70 % des décisions cliniques, tandis que les médecins consacrent plus de trois heures par jour à la documentation et à la prescription des tests. Selon une enquête de l'AMA, 57 % des médecins considèrent l'automatisation administrative via l'IA comme la plus grande opportunité offerte par l'IA en santé.
Labcorp (NYSE: LH) hat Test Finder vorgestellt, ein innovatives generatives KI-Tool, das in Zusammenarbeit mit Amazon Web Services (AWS) entwickelt wurde. Das Tool soll die Auswahl von Labortests für Gesundheitsdienstleister vereinfachen, indem es ihnen ermöglicht, Anfragen in einfacher Sprache einzugeben und daraufhin kuratierte Testempfehlungen zu erhalten.
Test Finder, entwickelt mit Amazon Bedrock und großer Sprachmodell-Technologie, bietet Zugriff auf Tausende von Labortests in verschiedenen therapeutischen Bereichen. Das Tool adressiert eine bedeutende Herausforderung im Gesundheitswesen, da Labortests nahezu 70 % der klinischen Entscheidungen beeinflussen, während Ärzte täglich über drei Stunden mit Dokumentation und Testbestellungen verbringen. Einer AMA-Umfrage zufolge sehen 57 % der Ärzte die administrative Automatisierung durch KI als die größte Chance für KI im Gesundheitswesen.
- First-of-its-kind generative AI tool implementation in laboratory test selection
- Partnership with AWS leveraging enterprise-grade AI infrastructure and HIPAA-compliant security
- 24/7 availability on Labcorp.com platform
- Potential to reduce administrative burden and improve healthcare provider efficiency
- None.
Insights
Labcorp's new AI Test Finder tool represents strategic innovation that could strengthen competitive positioning and potentially drive increased test volume.
Labcorp's introduction of Test Finder represents a strategic technological advancement in the laboratory services sector. By leveraging generative AI through Amazon Bedrock, Labcorp is directly addressing a significant pain point for healthcare providers - the time-consuming process of selecting appropriate laboratory tests from complex menus.
The timing is particularly strategic given the broader healthcare landscape. With providers spending over three hours daily on administrative tasks including test ordering, and 57% of physicians identifying administrative automation as AI's greatest healthcare opportunity (according to AMA survey data), Labcorp is positioning this tool to address genuine market needs.
From a competitive standpoint, being described as "first-of-its-kind" suggests Labcorp is establishing an early mover advantage in applying generative AI to laboratory test selection. This innovation could create meaningful differentiation from competitors like Quest Diagnostics in the highly competitive laboratory services market.
The implementation covers key therapeutic areas including oncology, women's health, neurology, and autoimmune disease - all high-value testing segments. By simplifying access to these tests, Labcorp could potentially drive increased test utilization and revenue across these profitable categories.
While financial projections aren't specified, this innovation aligns with healthcare's broader shift toward efficiency-enhancing technologies. By reducing friction in the test ordering process, Labcorp could potentially capture greater market share while simultaneously addressing provider burnout - a win-win proposition that demonstrates forward-thinking strategic planning.
Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search
Developed in collaboration with Amazon Web Services, Test Finder is now available on Labcorp.com
Laboratory testing plays a critical role in healthcare, informing nearly
"Clinicians are under increasing pressure to do more with less," said Dr. Brian Caveney, Labcorp's chief medical and scientific officer. "Test Finder is designed to ease that burden by providing a faster, more intuitive way to navigate complex test menus, conduct research and identify the right tests, so clinicians can focus on what matters most: their patients."
Key Features of Labcorp's Test Finder
Now available on Labcorp.com, Test Finder was developed using Amazon Bedrock and large language model (LLM) technology. The tool enables providers to ask questions or describe conditions in plain language and receive a detailed list of suggested tests and descriptions based on their input. Additional benefits include:
- Access to thousands of lab tests across key therapeutic areas, including oncology, women's health, neurology, autoimmune disease and more
- Faster, more efficient navigation that reduces time spent on test selection
- Available 24/7 on Labcorp.com
"Labcorp's AI implementation underscores the transformative power of responsible generative AI in healthcare, setting a new industry standard for clinical workflow optimization," said Dr. Rowland Illing, global chief medical officer at AWS. "By leveraging AWS' enterprise-grade AI infrastructure and HIPAA-compliant security controls, Labcorp is revolutionizing how healthcare providers access comprehensive diagnostic information, enabling faster decisions that can directly impact patient care outcomes."
"Test Finder is a powerful example of how we're using technology to simplify complexity," said Bola Oyegunwa, Ph.D., Labcorp's chief information and technology officer. "By integrating generative AI, we're not only improving the provider experience, we're laying the foundation for smarter, more connected healthcare solutions that scale with the needs of our customers."
Labcorp anticipates sharing additional updates and announcements related to Test Finder in the coming weeks. For more information, visit www.labcorp.com.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-introduces-test-finder-a-first-of-its-kind-generative-ai-tool-to-simplify-lab-test-search-302517300.html
SOURCE Labcorp